FDA NDC Directory · JSON-LD · Markdown

ZYNRELEF

NDC 47426-501 · HUMAN PRESCRIPTION DRUG · SOLUTION

Generic nameBUPIVACAINE and MELOXICAM
Labeler / ManufacturerHeron Therapeutics, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA211988
Dosage form / routeSOLUTION · INFILTRATION
Active ingredientsBUPIVACAINE (400 mg/14mL)
MELOXICAM (12 mg/14mL)
Marketing started20241201
Package count1

External sources

Source: openFDA. Public-domain (CC0).